Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CANAGLIFLOZIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | CANAGLIFLOZIN |
| Key Genes/Proteins | MTOR, NLRP3, PARKIN, PINK1, SIRT3 |
| Related Diseases | AUTOPHAGY, DIABETES, DOPAMINE, MITOPHAGY, NEURODEGENERATION |
graph TD
CANAGLIFLOZIN[CANAGLIFLOZIN]
CANAGLIFLOZIN -->|treats| Diabetic_Cardiomyopathy[Diabetic Cardiomyopathy]
CANAGLIFLOZIN -->|activates| PINK1_Parkin_Mitophagy[PINK1-Parkin Mitophagy]
CANAGLIFLOZIN -->|activates| PINK1[PINK1]
CANAGLIFLOZIN -->|activates| PARKIN[PARKIN]
CANAGLIFLOZIN -->|targets| Cardiomyocyte[Cardiomyocyte]
CANAGLIFLOZIN -->|promotes| MITOPHAGY[MITOPHAGY]
CANAGLIFLOZIN -.protects against.-> NLRP3[NLRP3]
CANAGLIFLOZIN -.protects against.-> DIABETES[DIABETES]
CANAGLIFLOZIN -->|inhibits| NEURODEGENERATION[NEURODEGENERATION]| Target | Relation | Type | Str |
|---|---|---|---|
| Diabetic Cardiomyopathy | treats | disease | 0.95 |
| PINK1-Parkin Mitophagy | activates | pathway | 0.90 |
| Cardiomyocyte | targets | cell_type | 0.80 |
| MITOPHAGY | promotes | process | 0.80 |
| PINK1 | activates | gene | 0.80 |
| PARKIN | activates | gene | 0.80 |
| DIABETES | protects_against | disease | 0.65 |
| NEURODEGENERATION | inhibits | phenotype | 0.65 |
| DOPAMINE | activates | phenotype | 0.65 |
| PINK1 | treats | gene | 0.65 |
| NLRP3 | protects_against | gene | 0.65 |
| NLRP3 | associated_with | gene | 0.50 |
| SIRT3 | associated_with | gene | 0.50 |
| DOPAMINE | associated_with | phenotype | 0.50 |
| MTOR | associated_with | gene | 0.50 |
| AUTOPHAGY | associated_with | phenotype | 0.50 |
| PARKIN | associated_with | gene | 0.45 |
| PINK1 | associated_with | gene | 0.45 |
| MITOPHAGY | associated_with | phenotype | 0.45 |
| DIABETES | associated_with | disease | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NEURODEGENERATION | associated_with | phenotype | 0.50 |
| CARDIOMYOCYTES | associated_with | cell_type | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CANAGLIFLOZIN in their description or question text
No additional research found